- Case report of a patient with generalized NSCLC with high PD-L1 expression treated with pembrolizumab2020 | Publication without faculty affiliation
- Monotherapy with pembrolizumab in the first-line treatment of non-small cell lung cancer with a high expression of PD-L1 >= 50 %2020 | Faculty of Medicine in Pilsen
- PD-L1 testing - new challenge in predictive diagnostics of non-small cell lung carcinoma2016 | Faculty of Medicine in Hradec Králové
- Testování exprese PD-L1 u nemalobuněčného karcinomu plic2017 | First Faculty of Medicine
- Influence of neoadjuvant achemoradiotherpy on PD-L1 expression change in rectal cancer patients2019 | First Faculty of Medicine, Central Library of Charles University
- Biologically targeted treatment in non-small cell lung cancer or "do we always have mutations and PD-L1 examined?" - case report2021 | Faculty of Medicine in Pilsen
- Terapie mnohočetného spinaliomu pomocí anti-PD-L12020 | Third Faculty of Medicine
- Immunotherapy in squamous NSCLC - nivolumab clinical data, our experiences with nivolumab treatment2018 | Faculty of Medicine in Pilsen
- The expression of PD-L1 in patients with castrate prostate cancer treated with enzalutamide2018 | First Faculty of Medicine
- PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma2018 | Faculty of Medicine in Pilsen
- The prognostic effect of neoadjuvant chemoradiotherapy on the change of PD-L1 expression in patients with locally advanced rectal adenocarcinoma2017 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- HER-3 molecular classification, expression of PD-L1 and clinical importance in breast cancer2022 | First Faculty of Medicine, Third Faculty of Medicine
- Expression and prognostic significance of programmed death-ligand 1 (PD-L1) in Merkel cell carcinoma2019 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Plasma PD-L1 as a biomarker in the clinical management of glioblastoma multiforme-a retrospective cohort study2023 | Publication without faculty affiliation
- Výborná odpověď na léčbu pembrolizumabem u nemocné se 100% expresí PD-L12019 | Third Faculty of Medicine
- Laboratory Parameters Associated with Inflammation Do Not Affect PD-L1 Expression in Non-small Cell Lung Cancer2022 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, Central Library of Charles University, Second Faculty of Medicine
- Efficacy and toxicity of combined immunochemotherapy in the treatment of patients with bronchogenic carcinoma with PD-L1 receptor expression < 1 % - case report2023 | First Faculty of Medicine
- PD-1, PD-L1 and PD-L2 Expression in Mantle Cell Lymphoma and Healthy Population2020 | First Faculty of Medicine
- Testování PD-L1 pro všechny pacienty s pokročilým uroteliálním karcinomem2020 | Publication without faculty affiliation
- Durvalumab in the treatment of small cell lung cancer2020 | Faculty of Medicine in Pilsen
- Immunoterapy related toxicities2017 | Faculty of Medicine in Hradec Králové
- PD-L1 immunohistochemistry in non-small-cell lung cancer: unraveling differences in staining concordance and interpretation2021 | Faculty of Medicine in Hradec Králové
- A noninterventional, multinational study to assess PD-L1 expression in cytological and histological lung cancer specimens2020 | Publication without faculty affiliation
- Comedication with corticosteroids and nonsteroidal antiphlogistics does not affect PD-L1 expression in non-small cell lung cancer2022 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University, Second Faculty of Medicine
- Loss of SATB2 expression correlates with cytokeratin 7 and PD-L1 tumor cell positivity and aggressiveness in colorectal cancer2022 | First Faculty of Medicine, Third Faculty of Medicine
- CheckMate 9LA trial: commentary and clinical case report of patient with cerebellar metastasis2023 | First Faculty of Medicine
- Comedication with corticosteroids and nonsteroidal antiphlogistics does not affect PD-L1 expression in non-small cell lung cancer2022 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, Central Library of Charles University, Second Faculty of Medicine
- PD-L1 and PD-1 Expression in Thyroid Follicular Epithelial Dysplasia: Hashimoto Thyroiditis Related Atypia and Potential Papillary Carcinoma Precursor2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Atezolizumab in the first-line treatment of non-small cell lung cancer - the IMpower110 trial2022 | First Faculty of Medicine
- High tumour mutational burden is associated with strong PD-L1 expression, HPV negativity, and worse survival in penile squamous cell carcinoma: an analysis of 165 cases2023 | First Faculty of Medicine, Third Faculty of Medicine